
Dana Doskaliuk
@DDoskaliuk
Followers
508
Following
1K
Media
22
Statuses
1K
#MD, #PhD_student with interests in the field of #rheumatology and particularly #pathophysiology of #systemicsclerosis,@EMEUNET member, regular #reviewer
Ivano-Frankivsk, Ukraine
Joined May 2019
RT @ArmenYuri: Beyond the Keyboard: Academic Writing in the Era of ChatGPT.@DDoskaliuk @hande_snc @abdulvahap_md @BurhanFatihKoy1 @OlenaZim….
pmc.ncbi.nlm.nih.gov
0
8
0
🚨 New Publication Alert! 🚨.Our latest review on SSc-ILD explores the immune–fibrotic crosstalk, current therapies, & exciting frontiers like CAR-T, MSCs, & epigenetic modulators.🔗.#Rheumatology #Pulmonology #SScILD #Autoimmunity #Fibrosis.
journals.sagepub.com
Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is a leading cause of morbidity and mortality in systemic sclerosis, marked by complex immunop...
1
1
2
RT @ArmenYuri: . Sebaceous cyst inflammation during ixekizumab therapy in psoriatic arthritis: case based review.@NPF @psoriasis_hub @Grap….
link.springer.com
Rheumatology International - Ixekizumab is a monoclonal antibody used in the treatment of moderate-to-severe psoriasis and psoriatic arthritis by targeting interleukin-17 A...
0
3
0
RT @ArmenYuri: Practice patterns and challenges in the referral, diagnosis, management, and monitoring of axial spondyloarthritis: insights….
link.springer.com
Rheumatology International - There is a dearth of literature exploring challenges faced by rheumatologists in the referral, diagnosis, and management of patients with suspected axial...
0
6
0
RT @LatikaGupta_: Very pleased to share that our first paper from the @EULAR_org #SocialMedia Study Group is now published! .This Declarati….
0
9
0
RT @cristianasieiro: 🚨 New in @bmj_rmdopen. New horizons in SSc treatment (2025).👉From AHSCT to CAR-T, bsAbs, FcRn & IFN inhibitors—SSc car….
rmdopen.bmj.com
Systemic sclerosis (SSc) is a rare, multisystem autoimmune disease characterised by vasculopathy, immune dysregulation, and progressive fibrosis, leading to significant morbidity and mortality. While...
0
8
0
RT @cristianasieiro: 💙 #SclerodermaDay 2025.Systemic sclerosis is rare—but the need for awareness, research & care is universal. From earl….
0
4
0
RT @EMEUNET: 🎉 Congratulations to the Winners of the Rheumavision Finals! 🎥✨. 🏆 Nicolas Degryse – Belgium.🏆 Fabio Ryser – Switzerland.🏆 Ann….
0
13
0
RT @EMEUNET: 📍 Pro tip from @EMEUNET.Trying to find your session at #EULAR2025?. 🔹 Lecture rooms starting with a letter (e.g. Room A, D. )….
0
5
0
RT @KragstrupTW: New feature at the Poster Hall at #eular2025. Bring your own head phones and join a poster tour with the App 📱🎧😎. @eular_….
0
2
0
RT @ArmenYuri: Rheumatology speaker introductions suggest gender bias: an evaluation of the 2022 American college of rheumatology convergen….
link.springer.com
Rheumatology International - Despite gender parity in the rheumatology workforce, biases may persist in speaker introductions at professional rheumatology meetings, as observed in other...
0
8
0
RT @ArmenYuri: Beyond the Keyboard: Academic Writing in the Era of ChatGPT
pubmed.ncbi.nlm.nih.gov
Beyond the Keyboard: Academic Writing in the Era of ChatGPT
0
4
0
RT @fake_journals: Peer reviews of peer reviews: A randomized controlled trial and other experiments .
0
6
0
RT @ArmenYuri: Causes for Retraction in the Biomedical Literature: A Systematic Review of Studies of Retraction Notices .@BurhanFatihKoy1 @….
pubmed.ncbi.nlm.nih.gov
Misconduct seems to be the most frequently recorded reason for retraction across empirical analyses of retraction notices, but other reasons are not negligible. Greater specificity of causes and...
0
3
0
RT @JkmsOrg: Artificial Intelligence in #PeerReview: Enhancing Efficiency While Preserving Integrity by @DDoskaliuk et al. ✅ #AI enhances e….
0
7
0
RT @ArmenYuri: Thyroid disease as a comorbidity in inflammatory rheumatic diseases.@DDoskaliuk @dr_emrebilgin @IoannisParodis @JK77775 @Abr….
link.springer.com
Rheumatology International - Thyroid disease is a common comorbidity in inflammatory rheumatic diseases (IRDs). It complicates disease management and treatment of IRDs. The interplay between...
0
5
0
RT @RheumKrakow: #PsoriaticArthritis vs. #RheumatoidArthritis: Endothelial Dysfunction & CV Risk by @JarosawNowakow6 et al. 🔗 https://t.co/….
0
4
0
RT @ArmenYuri: Editorial Strategy to Get a Scholarly Journal Indexed by Scopus.
pubmed.ncbi.nlm.nih.gov
Editorial Strategy to Get a Scholarly Journal Indexed by Scopus
0
6
0